White label – Pompe disease - ClinicalTrials.eu

Study on the Long-Term Safety of Bepranemab for Adults with Progressive Supranuclear Palsy

Not recruiting

1 1 1
Investigated Diseases:
- Progressive supranuclear palsy
Investigated Drugs:
- Bepranemab
Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Not recruiting

3 1 1 1
Investigated Drugs:
+10
Study of Ipatasertib with Trastuzumab and Pertuzumab for Patients with Advanced HER2-Positive Breast Cancer and PIK3CA Mutation

Not recruiting

1 1 1 1
Investigated Diseases:
- HER2 positive breast cancer
Investigated Drugs:
Study on Preventing Acute Kidney Injury in Cardiac Surgery Patients Using Dapagliflozin

Not recruiting

3 1 1 1
Investigated Drugs:
- Dapagliflozin
Study on Radiotherapy with Nimotuzumab and Vinorelbine for Newly Diagnosed Childhood and Adolescent Diffuse Intrinsic Pontine Glioma (DIPG) Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Brain stem glioma
Investigated Drugs:
- Nimotuzumab
- Vinorelbine Tartrate
Study Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Not recruiting

3 1 1 1
Investigated Drugs:
- Sacituzumab Govitecan
- Docetaxel
+4
Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

Not recruiting

3 1 1
Investigated Drugs:
- 1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
+1
Study on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

Not recruiting

2 1 1
Investigated Diseases:
- Alport’s syndrome
- Focal segmental glomerulosclerosis
Investigated Drugs:
- R3R01
Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Tofacitinib Citrate
- Tofacitinib
+4
Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Alendronate Sodium Monohydrate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies